Ipsen Receives CHMP Negative Opinion for Palovarotene as a Treatment for Fibrodysplasia Ossificans Progressiva in E.U. – Yahoo Finance
Ipsen to request re-examination of CHMP opinion on palovarotene as a potential treatment for fibrodysplasia ossificans progressiva in E.U.FOP is an ultra-rare disease that continuously and permanently causes abnormal bone formation.1 There are currently no…